143 related articles for article (PubMed ID: 10744735)
1. A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts.
Hueber AO; Zörnig M; Bernard AM; Chautan M; Evan G
J Biol Chem; 2000 Apr; 275(14):10453-62. PubMed ID: 10744735
[TBL] [Abstract][Full Text] [Related]
2. Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells.
Newton K; Kurts C; Harris AW; Strasser A
Curr Biol; 2001 Feb; 11(4):273-6. PubMed ID: 11250157
[TBL] [Abstract][Full Text] [Related]
3. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice.
Zörnig M; Hueber AO; Evan G
Curr Biol; 1998 Apr; 8(8):467-70. PubMed ID: 9550704
[TBL] [Abstract][Full Text] [Related]
4. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
Zhang J; Cado D; Chen A; Kabra NH; Winoto A
Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
[TBL] [Abstract][Full Text] [Related]
5. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes.
Newton K; Harris AW; Bath ML; Smith KG; Strasser A
EMBO J; 1998 Feb; 17(3):706-18. PubMed ID: 9450996
[TBL] [Abstract][Full Text] [Related]
6. The requirements for Fas-associated death domain signaling in mature T cell activation and survival.
Beisner DR; Chu IH; Arechiga AF; Hedrick SM; Walsh CM
J Immunol; 2003 Jul; 171(1):247-56. PubMed ID: 12817005
[TBL] [Abstract][Full Text] [Related]
7. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression.
Lüschen S; Ussat S; Scherer G; Kabelitz D; Adam-Klages S
J Biol Chem; 2000 Aug; 275(32):24670-8. PubMed ID: 10827087
[TBL] [Abstract][Full Text] [Related]
8. Enhanced basal AP-1 activity and de-regulation of numerous genes in T cells transgenic for a dominant interfering mutant of FADD/MORT1.
Chaneva S; Schneider G; Siegmund D; Wajant H; Mages J; Häcker G
Eur J Immunol; 2004 Nov; 34(11):3006-15. PubMed ID: 15376191
[TBL] [Abstract][Full Text] [Related]
9. An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells.
Morgan MJ; Thorburn J; Thomas L; Maxwell T; Brothman AR; Thorburn A
Cell Death Differ; 2001 Jul; 8(7):696-705. PubMed ID: 11464214
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).
Wajant H; Haas E; Schwenzer R; Muhlenbeck F; Kreuz S; Schubert G; Grell M; Smith C; Scheurich P
J Biol Chem; 2000 Aug; 275(32):24357-66. PubMed ID: 10823821
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustard.
Rosenthal DS; Velena A; Chou FP; Schlegel R; Ray R; Benton B; Anderson D; Smith WJ; Simbulan-Rosenthal CM
J Biol Chem; 2003 Mar; 278(10):8531-40. PubMed ID: 12482751
[TBL] [Abstract][Full Text] [Related]
12. Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activation.
Seino K; Setoguchi Y; Ogino T; Kayagaki N; Akiba H; Nakano H; Taniguchi H; Takada Y; Yuzawa K; Todoroki T; Fukuchi Y; Yagita H; Okumura K; Fukao K
Ann Surg; 2001 Nov; 234(5):681-8. PubMed ID: 11685033
[TBL] [Abstract][Full Text] [Related]
13. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction.
Wajant H; Johannes FJ; Haas E; Siemienski K; Schwenzer R; Schubert G; Weiss T; Grell M; Scheurich P
Curr Biol; 1998 Jan; 8(2):113-6. PubMed ID: 9427646
[TBL] [Abstract][Full Text] [Related]
14. The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation.
Thomas LR; Johnson RL; Reed JC; Thorburn A
J Biol Chem; 2004 Dec; 279(50):52479-86. PubMed ID: 15452120
[TBL] [Abstract][Full Text] [Related]
15. T cell-specific FADD-deficient mice: FADD is required for early T cell development.
Kabra NH; Kang C; Hsing LC; Zhang J; Winoto A
Proc Natl Acad Sci U S A; 2001 May; 98(11):6307-12. PubMed ID: 11353862
[TBL] [Abstract][Full Text] [Related]
16. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
Harper N; Hughes M; MacFarlane M; Cohen GM
J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
[TBL] [Abstract][Full Text] [Related]
17. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor.
Newton K; Harris AW; Strasser A
EMBO J; 2000 Mar; 19(5):931-41. PubMed ID: 10698935
[TBL] [Abstract][Full Text] [Related]
18. A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region.
Hua ZC; Sohn SJ; Kang C; Cado D; Winoto A
Immunity; 2003 Apr; 18(4):513-21. PubMed ID: 12705854
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of caspase or FADD function blocks proliferation but not MAP kinase-activation and interleukin-2-production during primary stimulation of T cells.
Mack A; Häcker G
Eur J Immunol; 2002 Jul; 32(7):1986-92. PubMed ID: 12115619
[TBL] [Abstract][Full Text] [Related]
20. Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD.
Thomas LR; Henson A; Reed JC; Salsbury FR; Thorburn A
J Biol Chem; 2004 Jul; 279(31):32780-5. PubMed ID: 15173180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
